Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment - Forbes

AFP Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment Forbes In yet another blow to a potential treatment for Alzheimer's disease, Baxter International Baxter International (BAX) said its late-stage clinical trial failed to meet its endpoints for “reducing cognitive decline and preserving functional abilities” for patients. UPDATE 2-Baxter's Alzheimer's disease drug fails in late-stage trial Reuters Baxter Says Alzheimer's Treatment Falls Short in Testing Wall Street Journal Alzheimer's Disease: IVIG Fails in Trial - MedPage Today MedPage Today MarketWatch - AFP - Newsday all 71 news articles »
Continue reading here:
Failure Of Baxter's Trial Another Blow To Alzheimer's Treatment -

Read more ...